Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.
about
Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic responseManagement of perioperative tumour necrosis factor α inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysisBeyond fat mass: exploring the role of adipokines in rheumatic diseasesAdiponectin and atherosclerosis in rheumatoid arthritisAdipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity.Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristicsPharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits.Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective studyPlasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage?Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways.Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis.The role of adipokines in connective tissue diseases.Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis.Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patientsMuscle density in rheumatoid arthritis: associations with disease features and functional outcomesAssociation of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis.Smoking Functions as a Negative Regulator of IGF1 and Impairs Adipokine Network in Patients with Rheumatoid ArthritisGreater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis.Urinary interleukin-6 as a predictor of radiographic progression in rheumatoid arthritis: A 3-year evaluation.Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases.Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study.Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort.Adipokines as potential biomarkers in rheumatoid arthritisObesity in rheumatoid arthritis.Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?Cardiometabolic comorbidities and rheumatic diseases: focus on the role of fat mass and adipokines.What's new in our understanding of the role of adipokines in rheumatic diseases?The influence of ageing on the development and management of rheumatoid arthritis.Adiponectin and leptin: new targets in inflammation.Emerging role of leptin in rheumatoid arthritis.Rheumatoid arthritis and metabolic syndrome.Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations.Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: A meta-analysis and systematic review.Prevalence of overweight in Moroccan patients with rheumatoid arthritis and its relationships with disease features.Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis.Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity.Patterns and predictors of joint damage as assessed by the rheumatoid arthritis articular damage (RAAD) score in South Africans with established rheumatoid arthritis.
P2860
Q26778275-2396631F-F296-463D-AAB1-78EBBE446A2BQ26786213-05AEA95D-ED13-47A3-8C76-4E1C475882BCQ26864855-24A0184C-CE7E-4885-8FEC-610118658CFCQ33790971-5132368F-6DB1-4E9F-B2FA-BA06A5AB061FQ34228799-FC0DD1CC-1A32-4A49-8D88-D0670EC8BCDAQ34233328-4E50763E-D780-4537-A5E2-FE81727255C2Q34389006-FC194CC5-44FC-4AC3-9289-9E5D0751B4B6Q34488394-115FB339-205C-4A29-BC82-CFBB38467E7AQ34901953-A6687849-BB86-47A2-908B-CA10394EA3A7Q35065164-063366CC-1B49-4CAB-8EC3-93CBF332A803Q35907720-41864641-0C2A-45CC-B937-20715245EA0FQ36001279-E40566C2-36D6-4152-AD91-CE7C8DAF2F62Q36095970-953ECF61-795F-47F4-A74E-EA9E190A471EQ36148660-38847C03-8DD8-44DF-8BD1-CA8C897B623BQ36297290-358F9E7A-0638-42F4-B1CF-014192AC1A96Q36464831-1BC9CB28-E1D0-4B08-B91D-1ACCB4CCDA48Q36528874-0E57402A-8081-4E86-ABF0-2FD8CA64E520Q36693727-FDB8FB9B-E739-4B48-A84C-6689F384F457Q36732733-B52751D2-2FED-40A5-9F94-06B9892EB047Q36732747-8F07750E-BC67-43F0-95F6-79B3F58BAB6BQ37330396-17856FC1-B90A-4060-A1F4-DCE6879ED0EBQ37385755-4BBF0D8F-2610-49E9-8481-F3966DA34F5DQ37389102-D727B2E1-73B6-4772-9F1A-DFB0611F8F6CQ37690729-85FEABDB-F5AC-471E-BD4F-E9AFF5F6E178Q37700750-1B67D104-1D27-4823-9929-B7D9CEB18AD0Q37801496-7614DBFF-6107-48FA-B73C-16297A00DE1EQ37845275-233F16F2-4D53-49FC-81E4-947674E99957Q37869467-28937308-B216-42EA-9A6E-37CB0EC69A98Q37909903-94818F1C-4291-4C4B-8E68-2F712086C8D6Q38115131-87723D97-EF94-4C0B-B30A-34C419044F8AQ38120068-988D5B79-0935-4114-8680-5EF6031983E9Q38209820-C7709A10-119B-4C22-AC59-EEC5CF094905Q38236740-0D33E727-72FD-443A-9489-8B6739EA2E4FQ38763702-B4035053-326A-412C-80A7-8C430D604A51Q38945485-38DB54C7-E372-46A4-A7A0-E00734D8B7F4Q38968920-DC5A1441-CA64-4110-B01F-2226A71D0605Q39091655-D1C44FCD-3D25-450A-8201-9D49A7A9C644Q39710835-184AFDE8-13E2-4D55-9E7A-4CAD9EDB4D24Q46149920-39098741-D468-4D5A-A03D-DDF95EE96C96Q46176650-61A46615-9111-4632-8036-56C93BD1BFDB
P2860
Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.
@en
Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.
@nl
type
label
Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.
@en
Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.
@nl
prefLabel
Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.
@en
Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Adiponectin is a mediator of t ...... amage in rheumatoid arthritis.
@en
P2093
Clifton O Bingham
Joan M Bathon
Jon T Giles
William M Scott
P2860
P304
P356
10.1002/ART.24789
P577
2009-09-01T00:00:00Z